Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Triumvira Immunologics
Sort By
Newest First
1 / 1
1 / 1
Clinical Trials
Triumvira Immunologics Announces Publication Demonstrating the Safety and Efficacy of TAC T Cells Targeting Claudin 18.2
Triumvira Immunologics Inc.
PR-10-24-NI-47
Oct 16, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02
Dec 15, 2023
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01
Sep 15, 2023
Financing
Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics
Triumvira Immunologics Inc.
PR-M08-20-NI-45
Aug 28, 2020
